The ASX has slipped as oil war tensions hit energy, and a2 Milk tanks on US baby formula recall scare.
Expanding from its core sleep apnoea franchise, Resmed has paid $500 million for a company with a treatment for the common restless leg syndrome.
In a key step toward a restart, ETM has outlined a JORC-compliant tin-tantalum-niobium resource for Penouta in Spain.
A scoping study for Legacy Minerals’ Mt Carrington project in NSW highlights the potential of its gold-silver resources to deliver robust returns.
Tylah Tully sits down with new Minrex CEO Max Piirto to to unpack what drew him to the company following its merger with Electrum.
